Enfermedad por virus ebola: actualización
Calle-Prieto, Fernando de la; Arsuaga-Vicente, Marta; Mora-Rillo, Marta; Arnalich-Fernandez, Francisco; Arribas, Jose Ramon.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 34(7): 452-460, ago.-sept. 2016. ilus, gaf, tab
Artículo en Español | IBECS (España) | ID: ibc-155490
Documentos relacionados
Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection.
Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone.
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.
Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.
Ebola Virus Disease and Current Therapeutic Strategies: A Review.
Efficiency of Field Laboratories for Ebola Virus Disease Outbreak during Chronic Insecurity, Eastern Democratic Republic of the Congo, 2018-2020.
Ebola virus disease: A review for the emergency medicine clinician.
Pan-ebolavirus protective therapy by two multifunctional human antibodies.
Recent advances in the treatment of Ebola disease: A brief overview.
Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions<sup>1</sup>.